Analysts notably raised price targets for Tesla to $410, Meta to $940 and SpaceX to $275, while Bank of America reiterated its Buy rating on CoreWeave with a $140 target. Goldman Sachs reaffirmed Buy ratings on Nvidia and IBM, and JPMorgan reiterated its Overweight rating on Meta, citing the development of its Muse agent and enterprise paths. In biotechnology, Cantor Fitzgerald initiated Celcuity at Overweight with a $140 target, while JPMorgan initiated Electra Pharmaceuticals at Overweight with a December 2027 target of $36. Other notable calls included upgrades to Block, ION, Omega Healthcare, WhiteHorse Financial, Kohl’s and CME, as well as Netflix’s downgrade to Peer Perform on growing competition.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
